NEW YORK (GenomeWeb) – Singlera Genomics said today that it has raised $60 million in Series A+ financing led by Green Pine Capital Partners and Prosperico Ventures.

La Jolla, California- and Shanghai-based Singlera said that it will use the funds to help expand the development and commercialization of its non-invasive genetic tests for early-stage cancer detection and to fund clinical validation studies. The firm said that it will also use the funds to further expand its research facilities and its TitanSeq and Monod platforms into new product lines.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Hundreds of scientists have signed a letter criticizing the open-access Plan S, ScienceInsider reports.

NPR speaks with Rep. Eddie Bernice Johnson (D-Texas) about the US House of Representatives science committee.

A start-up company aiming to match cancer patients to treatments closes after about six weeks, Stat News reports.

In PLOS this week: somatic mutation associations unearthed in thousands of cancer exomes, pathogen detection assay, and more.